ArticleInfectious diseases and therapy2023

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1.

Judith A Aberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.